Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease
- PMID: 14523054
- DOI: 10.1194/jlr.M300320-JLR200
Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease
Abstract
24S-hydroxycholesterol is a side-chain oxidized oxysterol formed in the brain that is continuously crossing the blood-brain barrier to reach the circulation. There may be an opposite flux of 27-hydroxycholesterol, which is formed to a lower extent in the brain than in most other organs. Here we measured cholesterol, lathosterol, 24S- and 27-hydroxycholesterol, and plant sterols in four different brain areas of deceased Alzheimer's disease (AD) patients and controls. 24S-hydroxycholesterol was decreased and 27-hydroxycholesterol increased in all the brain samples from the AD patients. The difference was statistically significant in four of the eight comparisons. The ratio of 27-hydroxycholesterol to 24S-hydroxycholesterol was significantly increased in all brain areas of the AD patients and also in the brains of aged mice expressing the Swedish Alzheimer mutation APP751. Cholesterol 24S-hydroxylase and 27-hydroxylase protein was not significantly different between AD patients and controls. A high correlation was observed between the levels of 24S-hydroxycholesterol and lathosterol in the frontal cortex of the AD patients but not in the controls. Most probably the high levels of 27-hydroxycholesterol are due to increased influx of this steroid over the blood-brain barrier and the lower levels of 24S-hydroxycholesterol to decreased production. The high correlation between lathosterol and 24-hydroxycholesterol is consistent with a close coupling between synthesis and metabolism of cholesterol in the frontal cortex of the AD brain.
Similar articles
-
Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease.Arch Neurol. 2003 Apr;60(4):510-5. doi: 10.1001/archneur.60.4.510. Arch Neurol. 2003. PMID: 12707064 Clinical Trial.
-
24S-hydroxycholesterol: a marker of brain cholesterol metabolism.Pharmacopsychiatry. 2003 Sep;36 Suppl 2:S102-6. doi: 10.1055/s-2003-43053. Pharmacopsychiatry. 2003. PMID: 14574622
-
The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.Curr Alzheimer Res. 2004 Feb;1(1):71-7. doi: 10.2174/1567205043480546. Curr Alzheimer Res. 2004. PMID: 15975088
-
The role of 24S-hydroxycholesterol in Alzheimer's disease.J Nutr Health Aging. 2003;7(1):37-41. J Nutr Health Aging. 2003. PMID: 12679839 Review.
-
Oxysterols and Alzheimer's disease.Acta Neurol Scand Suppl. 2006;185:43-9. doi: 10.1111/j.1600-0404.2006.00684.x. Acta Neurol Scand Suppl. 2006. PMID: 16866910 Review.
Cited by
-
Oxidized cholesterol as the driving force behind the development of Alzheimer's disease.Front Aging Neurosci. 2015 Jun 19;7:119. doi: 10.3389/fnagi.2015.00119. eCollection 2015. Front Aging Neurosci. 2015. PMID: 26150787 Free PMC article. Review.
-
Elevated cellular cholesterol in Familial Alzheimer's presenilin 1 mutation is associated with lipid raft localization of β-amyloid precursor protein.PLoS One. 2019 Jan 25;14(1):e0210535. doi: 10.1371/journal.pone.0210535. eCollection 2019. PLoS One. 2019. PMID: 30682043 Free PMC article.
-
Oxysterol research: a brief review.Biochem Soc Trans. 2019 Apr 30;47(2):517-526. doi: 10.1042/BST20180135. Epub 2019 Apr 1. Biochem Soc Trans. 2019. PMID: 30936243 Free PMC article. Review.
-
The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice.Neuroscience. 2010 Aug 11;169(1):109-15. doi: 10.1016/j.neuroscience.2010.04.026. Epub 2010 Apr 21. Neuroscience. 2010. PMID: 20416362 Free PMC article.
-
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease.Front Neurosci. 2024 Sep 11;18:1430465. doi: 10.3389/fnins.2024.1430465. eCollection 2024. Front Neurosci. 2024. PMID: 39323915 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical